{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T19:45:29Z","timestamp":1793389529782,"version":"4.5.0"},"reference-count":64,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T00:00:00Z","timestamp":1656547200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003776","name":"Newcastle upon Tyne Hospitals NHS Foundation Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003776","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000774","name":"Newcastle University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000774","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012295","name":"NIHR Newcastle Biomedical Research Centre","doi-asserted-by":"publisher","award":["BRC-1215-20001"],"award-info":[{"award-number":["BRC-1215-20001"]}],"id":[{"id":"10.13039\/501100012295","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["777377"],"award-info":[{"award-number":["777377"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalnutritionjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.clnu.2022.06.037","type":"journal-article","created":{"date-parts":[[2022,7,2]],"date-time":"2022-07-02T02:00:36Z","timestamp":1656727236000},"page":"1913-1931","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":205,"title":["The effectiveness and acceptability of Mediterranean diet and calorie restriction in non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis"],"prefix":"10.1016","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9229-4127","authenticated-orcid":false,"given":"Laura","family":"Haigh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5648-7725","authenticated-orcid":false,"given":"Colette","family":"Kirk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalil","family":"El Gendy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Gallacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Errington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3406-3002","authenticated-orcid":false,"given":"John C.","family":"Mathers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9518-0088","authenticated-orcid":false,"given":"Quentin M.","family":"Anstee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.clnu.2022.06.037_bib1","article-title":"Cost of non-alcoholic steatohepatitis in Europe and the USA: the GAIN study","volume":"2","author":"O'Hara","year":"2020","journal-title":"JHEP Rep"},{"issue":"6","key":"10.1016\/j.clnu.2022.06.037_bib2","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1002\/hep.30251","article-title":"Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"69","author":"Younossi","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.clnu.2022.06.037_bib3","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.metabol.2018.11.014","article-title":"Obesity and nonalcoholic fatty liver disease: from pathophysiology to therapeutics","volume":"92","author":"Polyzos","year":"2019","journal-title":"Metabolism"},{"issue":"6","key":"10.1016\/j.clnu.2022.06.037_bib4","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrgastro.2013.41","article-title":"Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis","volume":"10","author":"Anstee","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.clnu.2022.06.037_bib5","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1053\/j.gastro.2015.04.043","article-title":"Liver fibrosis, but No other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease","volume":"149","author":"Angulo","year":"2015","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.clnu.2022.06.037_bib6","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/hep.27368","article-title":"Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up","volume":"61","author":"Ekstedt","year":"2015","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.clnu.2022.06.037_bib7","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1053\/j.gastro.2020.01.043","article-title":"Association between fibrosis stage and outcomes of patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis","volume":"158","author":"Taylor","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clnu.2022.06.037_bib8","first-page":"1388","volume":"64","year":"2016","journal-title":"Hepatology"},{"issue":"18","key":"10.1016\/j.clnu.2022.06.037_bib9","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1056\/NEJMoa0907929","article-title":"Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis","volume":"362","author":"Sanyal","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"10215","key":"10.1016\/j.clnu.2022.06.037_bib10","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1016\/S0140-6736(19)33041-7","article-title":"Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial","volume":"394","author":"Younossi","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.clnu.2022.06.037_bib11","series-title":"Non-alcoholic fatty liver disease (NAFLD): assessment and management (NG49)","year":"2016"},{"issue":"4","key":"10.1016\/j.clnu.2022.06.037_bib12","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.jhep.2017.05.016","article-title":"Treatment of NAFLD with diet, physical activity and exercise","volume":"67","author":"Romero-Gomez","year":"2017","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.clnu.2022.06.037_bib13","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jhep.2011.06.010","article-title":"Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: a systematic review","volume":"56","author":"Thoma","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.clnu.2022.06.037_bib14","series-title":"The role of nutrients in the development, progression, and treatment of nonalcoholic fatty liver disease","first-page":"457","author":"Mouzaki","year":"2012"},{"issue":"12","key":"10.1016\/j.clnu.2022.06.037_bib15","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1016\/j.cgh.2017.06.011","article-title":"Lifestyle behavior change in patients with nonalcoholic fatty liver disease: A qualitative study of clinical practice","volume":"15","author":"Avery","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"7","key":"10.1016\/j.clnu.2022.06.037_bib16","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.cgh.2018.10.044","article-title":"Barriers and facilitators to mediterranean diet adoption by patients with nonalcoholic fatty liver disease in northern europe","volume":"17","author":"Haigh","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.clnu.2022.06.037_bib17","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.3390\/nu9101052","article-title":"Mediterranean diet and multi-ingredient-based interventions for the management of non-alcoholic fatty liver disease","volume":"9","author":"Su\u00e1rez","year":"2017","journal-title":"Nutrients"},{"issue":"25","key":"10.1016\/j.clnu.2022.06.037_bib18","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1056\/NEJMoa1800389","article-title":"Primary prevention of cardiovascular disease with a mediterranean diet supplemented with extra-virgin olive oil or nuts","volume":"378","author":"Estruch","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clnu.2022.06.037_bib19","author":"Higgins"},{"key":"10.1016\/j.clnu.2022.06.037_bib20","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.clnu.2022.06.037_bib21","series-title":"Systematic Reviews: CRD's guidance for undertaking reviews in health care","year":"2009"},{"key":"10.1016\/j.clnu.2022.06.037_bib22","author":"Higgins"},{"key":"10.1016\/j.clnu.2022.06.037_bib23","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.clnu.2022.06.037_bib24","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.clnu.2022.06.037_bib25","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2288-5-13","article-title":"Estimating the mean and variance from the median, range, and the size of a sample","volume":"5","author":"Hozo","year":"2005","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"10.1016\/j.clnu.2022.06.037_bib26","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/ije\/31.1.140","article-title":"Meta-analyses involving cross-over trials: methodological issues","volume":"31","author":"Elbourne","year":"2002","journal-title":"Int J Epidemiol"},{"issue":"5","key":"10.1016\/j.clnu.2022.06.037_bib27","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.jhep.2018.07.013","article-title":"An internet-based approach for lifestyle changes in patients with NAFLD: two-year effects on weight loss and surrogate markers","volume":"69","author":"Mazzotti","year":"2018","journal-title":"J\u00a0Hepatol"},{"issue":"11","key":"10.1016\/j.clnu.2022.06.037_bib28","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1136\/gutjnl-2020-323106","article-title":"Effect of green-Mediterranean diet on intrahepatic fat: the DIRECT PLUS randomised controlled trial","volume":"70","author":"Yaskolka Meir","year":"2021","journal-title":"Gut"},{"issue":"11","key":"10.1016\/j.clnu.2022.06.037_bib29","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1161\/CIRCULATIONAHA.117.030501","article-title":"Effect of distinct lifestyle interventions on mobilization of fat storage pools: CENTRAL magnetic resonance imaging randomized controlled trial","volume":"137","author":"Gepner","year":"2018","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.clnu.2022.06.037_bib30","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1093\/ajcn\/nqy307","article-title":"Potential effects of reduced red meat compared with increased fiber intake on glucose metabolism and liver fat content: a randomized and controlled dietary intervention study","volume":"109","author":"Willmann","year":"2019","journal-title":"Am J Clin Nutr"},{"issue":"3","key":"10.1016\/j.clnu.2022.06.037_bib31","article-title":"Treatment of NAFLD with intermittent calorie restriction or low-carb high-fat diet - a randomised controlled trial","volume":"3","author":"Holmer","year":"2021","journal-title":"JHEP Rep"},{"issue":"1","key":"10.1016\/j.clnu.2022.06.037_bib32","doi-asserted-by":"crossref","DOI":"10.1038\/srep36783","article-title":"Long-term lifestyle interventions in middle-aged and elderly men with nonalcoholic fatty liver disease: a randomized controlled trial","volume":"6","author":"Dong","year":"2016","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.clnu.2022.06.037_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/nu13010015","article-title":"Calorie-restricted mediterranean and low-fat diets affect fatty acid status in individuals with nonalcoholic fatty liver disease","volume":"13","author":"Ristic-Medic","year":"2021","journal-title":"Nutrients"},{"issue":"5","key":"10.1016\/j.clnu.2022.06.037_bib34","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1002\/hep.30076","article-title":"Ad libitum mediterranean and low-fat diets both significantly reduce hepatic steatosis: a randomized controlled trial","volume":"68","author":"Properzi","year":"2018","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.clnu.2022.06.037_bib35","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1017\/S000711451800137X","article-title":"Improvements in clinical characteristics of patients with non-alcoholic fatty liver disease, after an intervention based on the Mediterranean lifestyle: a randomised controlled clinical trial","volume":"120","author":"Katsagoni","year":"2018","journal-title":"Br J Nutr"},{"issue":"4","key":"10.1016\/j.clnu.2022.06.037_bib36","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1007\/s12603-016-0809-8","article-title":"Effect of a low glycemic index Mediterranean diet on non-alcoholic fatty liver disease. A randomized controlled clinici trial","volume":"21","author":"Misciagna","year":"2017","journal-title":"J\u00a0Nutr Health Aging"},{"issue":"1","key":"10.1016\/j.clnu.2022.06.037_bib37","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jhep.2013.02.012","article-title":"The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease","volume":"59","author":"Ryan","year":"2013","journal-title":"J\u00a0Hepatol"},{"issue":"8","key":"10.1016\/j.clnu.2022.06.037_bib38","doi-asserted-by":"crossref","first-page":"870","DOI":"10.3390\/nu9080870","article-title":"Effect of mediterranean diet and antioxidant formulation in non-alcoholic fatty liver disease: a randomized study","volume":"9","author":"Abenavoli","year":"2017","journal-title":"Nutrients"},{"issue":"10","key":"10.1016\/j.clnu.2022.06.037_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/nu11102543","article-title":"The metabolic and hepatic impact of two personalized dietary strategies in subjects with obesity and nonalcoholic fatty liver disease: the fatty liver in obesity (FLiO) randomized controlled trial","volume":"11","author":"Marin-Alejandre","year":"2019","journal-title":"Nutrients"},{"issue":"4","key":"10.1016\/j.clnu.2022.06.037_bib40","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3748\/wjg.v25.i4.509","article-title":"Intestinal permeability after Mediterranean diet and low-fat diet in non-alcoholic fatty liver disease","volume":"25","author":"Biolato","year":"2019","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.clnu.2022.06.037_bib41","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.clnesp.2020.04.004","article-title":"Effect of lifestyle modification education based on health belief model in overweight\/obese patients with non-alcoholic fatty liver disease: a parallel randomized controlled clinical trial","volume":"38","author":"Nourian","year":"2020","journal-title":"Clinical Nutrition ESPEN"},{"issue":"2","key":"10.1016\/j.clnu.2022.06.037_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/nu13020629","article-title":"Energy expenditure improved risk factors associated with renal function loss in NAFLD and MetS patients","volume":"13","author":"Abbate","year":"2021","journal-title":"Nutrients"},{"issue":"3","key":"10.1016\/j.clnu.2022.06.037_bib43","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1017\/S0007114519002769","article-title":"Whole-grain consumption and its effects on hepatic steatosis and liver enzymes in patients with non-alcoholic fatty liver disease: a randomised controlled clinical trial","volume":"123","author":"Dorosti","year":"2020","journal-title":"Br J Nutr"},{"key":"10.1016\/j.clnu.2022.06.037_bib44","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/1053710","article-title":"The effects of extra virgin olive oil on alanine aminotransferase, aspartate aminotransferase, and ultrasonographic indices of hepatic steatosis in nonalcoholic fatty liver disease patients undergoing low calorie diet","volume":"2018","author":"Shidfar","year":"2018","journal-title":"Canadian journal of gastroenterology & hepatology"},{"key":"10.1016\/j.clnu.2022.06.037_bib45","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.nut.2018.02.021","article-title":"Olive oil lessened fatty liver severity independent of cardiometabolic correction in patients with non-alcoholic fatty liver disease: a randomized clinical trial","volume":"57","author":"Rezaei","year":"2019","journal-title":"Nutrition"},{"key":"10.1016\/j.clnu.2022.06.037_bib46","series-title":"Community-based lifestyle modification programme for non-alcoholic fatty liver disease: A randomized controlled trial","author":"Wong","year":"2013"},{"issue":"1","key":"10.1016\/j.clnu.2022.06.037_bib47","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-16159-x","article-title":"Effect of aerobic exercise and diet on liver fat in pre-diabetic patients with non-alcoholic-fatty-liver-disease: a randomized controlled trial","volume":"7","author":"Cheng","year":"2017","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.clnu.2022.06.037_bib48","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.3945\/ajcn.110.007674","article-title":"Short-term weight loss and hepatic triglyceride reduction: evidence of a metabolic advantage with dietary carbohydrate restriction","volume":"93","author":"Browning","year":"2011","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"10.1016\/j.clnu.2022.06.037_bib49","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-47763-8","article-title":"A\u00a0randomised controlled trial on the effectiveness and adherence of modified alternate-day calorie restriction in improving activity of non-alcoholic fatty liver disease","volume":"9","author":"Johari","year":"2019","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.clnu.2022.06.037_bib50","article-title":"A\u00a0randomized controlled trial comparing effects of a low-energy diet with n-3 polyunsaturated fatty acid supplementation in patients with non-alcoholic fatty liver disease","volume":"24","author":"Shojasaadat","year":"2019","journal-title":"J\u00a0Res Med Sci"},{"issue":"1","key":"10.1016\/j.clnu.2022.06.037_bib51","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/hep.23276","article-title":"Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis","volume":"51","author":"Promrat","year":"2010","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.clnu.2022.06.037_bib52","doi-asserted-by":"crossref","first-page":"279","DOI":"10.15403\/jgld-197","article-title":"Effects of dietary intervention on gut microbiota and metabolic-nutritional profile of outpatients with non-alcoholic steatohepatitis: a randomized clinical trial","volume":"28","author":"Ghetti","year":"2019","journal-title":"Journal of Gastrointestinal and Liver Diseases"},{"issue":"12A","key":"10.1016\/j.clnu.2022.06.037_bib53","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1017\/S1368980011002515","article-title":"Mediterranean diet pyramid today. Science and cultural updates","volume":"14","author":"Bach-Faig","year":"2011","journal-title":"Publ Health Nutr"},{"issue":"6","key":"10.1016\/j.clnu.2022.06.037_bib54","article-title":"Lifestyle modifications for nonalcohol-related fatty liver disease: a network meta-analysis","volume":"6","author":"Buzzetti","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.clnu.2022.06.037_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nut.2014.06.011","article-title":"Dietary carbohydrate restriction as the first approach in diabetes management: critical review and evidence base","volume":"31","author":"Feinman","year":"2015","journal-title":"Nutrition"},{"issue":"3","key":"10.1016\/j.clnu.2022.06.037_bib56","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1055\/s-0041-1723751","article-title":"Effects of mediterranean diet in patients with nonalcoholic fatty liver disease: a systematic review, meta-analysis, and meta-regression analysis of randomized controlled trials","volume":"41","author":"Kawaguchi","year":"2021","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.clnu.2022.06.037_bib57","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.clnesp.2019.10.008","article-title":"The effect of a Mediterranean diet on metabolic parameters in patients with non-alcoholic fatty liver disease: a systematic review of randomized controlled trials","volume":"35","author":"Moosavian","year":"2020","journal-title":"Clin Nutr ESPEN"},{"issue":"11","key":"10.1016\/j.clnu.2022.06.037_bib58","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.jacc.2010.09.073","article-title":"The effect of Mediterranean diet on metabolic syndrome and its components: a meta-analysis of 50 studies and 534,906 individuals","volume":"57","author":"Kastorini","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.clnu.2022.06.037_bib59","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1093\/nutrit\/nux026","article-title":"Challenges in conducting clinical nutrition research","volume":"75","author":"Weaver","year":"2017","journal-title":"Nutr Rev"},{"issue":"1","key":"10.1016\/j.clnu.2022.06.037_bib60","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1365-277X.2009.00989.x","article-title":"Adoption and maintenance of a Mediterranean diet in patients with coronary heart disease from a Northern European population: a pilot randomised trial of different methods of delivering Mediterranean diet advice","volume":"23","author":"Logan","year":"2010","journal-title":"J\u00a0Hum Nutr Diet"},{"issue":"4","key":"10.1016\/j.clnu.2022.06.037_bib61","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.maturitas.2015.07.029","article-title":"The Mediterranean diet among British older adults: its understanding, acceptability and the feasibility of a randomised brief intervention with two levels of dietary advice","volume":"82","author":"Lara","year":"2015","journal-title":"Maturitas"},{"issue":"12","key":"10.1016\/j.clnu.2022.06.037_bib62","doi-asserted-by":"crossref","DOI":"10.3390\/nu10121905","article-title":"Changes in dietary intake and adherence to the NU-age diet following a one-year dietary intervention among European older adults-results of the NU-age randomized trial","volume":"10","author":"Berendsen","year":"2018","journal-title":"Nutrients"},{"issue":"4","key":"10.1016\/j.clnu.2022.06.037_bib63","first-page":"192","article-title":"MR quantitative biomarkers of non-alcoholic fatty liver disease: technical evolutions and future trends","volume":"3","author":"Ligabue","year":"2013","journal-title":"Quant Imag Med Surg"},{"key":"10.1016\/j.clnu.2022.06.037_bib64","first-page":"109","article-title":"Practical diagnosis and staging of nonalcoholic fatty liver disease: A narrative review","author":"Gallacher","year":"2018","journal-title":"Eur Med J"}],"container-title":["Clinical Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S026156142200231X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S026156142200231X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T01:08:05Z","timestamp":1759367285000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S026156142200231X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":64,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S026156142200231X"],"URL":"https:\/\/doi.org\/10.1016\/j.clnu.2022.06.037","relation":{},"ISSN":["0261-5614"],"issn-type":[{"value":"0261-5614","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effectiveness and acceptability of Mediterranean diet and calorie restriction in non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnu.2022.06.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}